salvin has been researched along with Cardiac Toxicity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bhanja, S; Bhattacharya, H; Bhattacharyya, C; Bhowmick, S; Bhowmik, M; Chakraborty, P; Das, J; Dewanjee, S; Joardar, S; Manna, P; Saha, A; Sil, PC | 1 |
Hu, S; Huang, M; Ju, H; Liu, B; Liu, Z; Mao, S; Wu, G; Yang, M | 1 |
Yang, JJ; Zhang, HS; Zhang, QL | 1 |
3 other study(ies) available for salvin and Cardiac Toxicity
Article | Year |
---|---|
Carnosic acid attenuates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and its concomitant pathological consequences.
Topics: Abietanes; Animals; Antioxidants; Apoptosis; Cardiotoxicity; Doxorubicin; Fibrosis; Inflammation; Mice; Myocytes, Cardiac; Oxidative Stress; Rats | 2022 |
Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
Topics: Animals; Apoptosis; Cardiotoxicity; Doxorubicin; Heme Oxygenase-1; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Signal Transduction | 2023 |
Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Topics: Abietanes; Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Autophagy; Cardiotoxicity; Carvedilol; Cell Line; Cytokines; Doxorubicin; Drug Synergism; Inflammation; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Rats; Signal Transduction | 2019 |